Neoadjuvant chemotherapy for high‐risk prostatic adenocarcinoma

INTRODUCTION: Neoadjuvant chemotherapy in high‐risk, locally advanced prostate cancer remains an understudied area of prostate cancer. Chemotherapy continues to be a viable option. The combination with surgery may be desired but lacks data for complete recommendation. CASE PRESENTATION: We demonstra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:IJU Case Rep
Main Authors: Brunner, Robert, Buck, Bradley, Giffen, Zane, Murtagh, Daniel, Lewis, Terrence, Gatto‐Weis, Cara, Sindhwani, Puneet
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7292178/
https://ncbi.nlm.nih.gov/pubmed/32743374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iju5.12031
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados